MarketCapTrends
OGEN

Oragenics Inc. (OGEN)

NYSE · Healthcare

Oragenics Inc. annual/quarterly shareholder equity history from 2010 to 2023. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Oragenics Inc. shareholder equity for the quarter ending December 31, 2023 were 3.2M, a 75.65% decrease year-over-year.
  • Oragenics Inc. shareholder equity for 2023 were 3.2M, a 75.65% decrease from 2022.
  • Oragenics Inc. shareholder equity for 2022 were 13.0M, a 50.88% decrease from 2021.
  • Oragenics Inc. shareholder equity for 2021 were 26.5M, a 319.33% increase from 2017.
  • Oragenics Inc. shareholder equity for 2017 were 6.3M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Oragenics Inc. Annual Shareholder Equity (Millions of US $)
2023$3
2022$13
2021$26
2017$6
2016$3
2015$5
2014$10
2013$16
2012$9
2011$-8
2010$-2
Oragenics Inc. Quarterly Shareholder Equity (Millions of US $)
2023-12-31$3
2022-12-31$13
2021-12-31$26
2017-12-31$6
2016-12-31$3
2015-12-31$5
2014-12-31$10
2013-12-31$16
2012-12-31$9
2011-12-31$-8
2010-12-31$-2

Oragenics Inc. Shareholder Equity — FAQ

Oragenics Inc. (OGEN) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see OGEN's shareholder equity history?

The chart and table above show Oragenics Inc.'s shareholder equity by year and by quarter, including the growth rate.